clorgyline has been researched along with Hodgkin Disease in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, PC | 1 |
| Siddiqi, IN | 1 |
| Mottok, A | 1 |
| Loo, EY | 1 |
| Wu, CH | 1 |
| Cozen, W | 1 |
| Steidl, C | 1 |
| Shih, JC | 1 |
1 other study available for clorgyline and Hodgkin Disease
| Article | Year |
|---|---|
Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.
Topics: Cell Line, Tumor; Clorgyline; Epstein-Barr Virus Infections; Female; Hodgkin Disease; Humans; Male; | 2017 |